Algernon Pharmaceuticals, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Algernon Pharmaceuticals Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Algernon Pharmaceuticals Inc - Ordinary Shares - Class A market cap is $2.4M.
What is the 52-week high for Algernon Pharmaceuticals Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Algernon Pharmaceuticals Inc - Ordinary Shares - Class A 52 week high is $0.1225 as of September 07, 2025.
What is the 52-week low for Algernon Pharmaceuticals Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Algernon Pharmaceuticals Inc - Ordinary Shares - Class A 52 week low is $0.055 as of September 07, 2025.
What is Algernon Pharmaceuticals Inc - Ordinary Shares - Class A stock price today?
Algernon Pharmaceuticals Inc - Ordinary Shares - Class A stock price today is $0.07.
What was Algernon Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday?
Algernon Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday was $0.07.
What is the PE ratio of Algernon Pharmaceuticals Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Algernon Pharmaceuticals Inc - Ordinary Shares - Class A’s P/E ratio is -1.11.
What is the Price-to-Book ratio of Algernon Pharmaceuticals Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Algernon Pharmaceuticals Inc - Ordinary Shares - Class A P/B ratio is 1.3769.
What is the 50-day moving average of Algernon Pharmaceuticals Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Algernon Pharmaceuticals Inc - Ordinary Shares - Class A 50-day moving average is $0.0678.
